Hubei Goto Biopharm Co.,Ltd. (300966.SZ)

CNY 17.5

(-0.91%)

Market Cap (In CNY)

2.01 Billion

Revenue (In CNY)

566.39 Million

Net Income (In CNY)

23 Million

Avg. Volume

2.31 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
12.03-25.7
PE
-
EPS
-
Beta Value
0.126
ISIN
CNE100004K94
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Zubin Xi
Employee Count
-
Website
https://www.gotobiopharm.com/en
Ipo Date
2021-04-09
Details
Hubei Goto Biopharm Co.,Ltd. engages in the production and sale of steroid hormone API's and intermediates in China. It offers starting materials, such as 9a-hydroxy-4-androstenedione(9a-OHAD), bisnoralcohol(BA), sitolactone, 1.4-androstadienedione(ADD), and 4-androstenedione(4-AD); intermediates, including estrogens, progesterone, nonsteroids, other hormones, and corticosteroids; and other pharmaceutical raw materials. The company was founded in 2006 and is based in Yicheng, China.